Professor John David Fraser

Profile Image
Dean Medical & Health Sciences

Research | Current

Research interests

  • Microbial genomics
  • Bacterial virulence
  • Host/pathogen interactions
  • Immune recognition
  • Superantigens
  • Staphylococcus
  • Gram positive infections
  • Innate Immunity

Selected publications and creative works (Research Outputs)

  • Li, Y., Clow, F., Fraser, J. D., & Lin, F. (2018). Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis. JOURNAL OF MOLECULAR MEDICINE-JMM, 96 (9), 965-974. 10.1007/s00109-018-1678-x
  • Jones, S., Moreland, N. J., Zancolli, M., Raynes, J., Loh, J. M. S., Smeesters, P. R., ... Goldblatt, D. (2018). Development of an opsonophagocytic killing assay for group a streptococcus. Vaccine, 36 (26), 3756-3763. 10.1016/j.vaccine.2018.05.056
    Other University of Auckland co-authors: Nikki Moreland, Jacelyn Loh, Jeremy Raynes
  • Langley, R. J., Ting, Y. T., Clow, F., Young, P. G., Radcliff, F. J., Choi, J. M., ... Fraser, J. D. (2017). Staphylococcal enterotoxin-like X (SElX) is a unique superantigen with functional features of two major families of staphylococcal virulence factors. PLoS Pathogens, 13 (9).10.1371/journal.ppat.1006549
    Other University of Auckland co-authors: Ries Langley, Paul Young, Fiona Radcliff
  • Ramsland, P. A., Soliman, C., Aguilar, M. I., Williams, R. J., Fraser, J. D., & Wines, B. D. (2017). Chasing the tail of human IgA through rational design of peptide mimics of a Staphylococcus aureus protein. Paper presented at 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back, Jerusalem, ISRAEL. 10 September - 14 September 2017. FEBS JOURNAL. (pp. 1).
  • Radcliff, F. J., Clow, F., Mahadevan, M., Johnston, J., Proft, T., Douglas, R. G., & Fraser, J. D. (2017). A potential role for staphylococcal and streptococcal superantigens in driving skewing of TCR Vβ subsets in tonsillar hyperplasia. Medical Microbiology and Immunology, 206 (4), 337-346. 10.1007/s00430-017-0510-5
    Other University of Auckland co-authors: Richard Douglas, Fiona Radcliff, Thomas Proft, James Johnston
  • Schödel F, Moreland, N. J., Wittes, J. T., Mulholland, K., Frazer, I., Steer, A. C., ... Carapetis, J. (2017). Clinical development strategy for a candidate group A streptococcal vaccine. Vaccine, 35 (16), 2007-2014. 10.1016/j.vaccine.2017.02.060
    Other University of Auckland co-authors: Nikki Moreland
  • Williamson, D. A., Smeesters, P. R., Steer, A. C., Morgan, J., Davies, M., Carter, P., ... Moreland, N. J. (2016). Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development. BMC Infectious Diseases, 16 (561)10.1186/s12879-016-1891-6
    Other University of Auckland co-authors: Nikki Moreland
  • Li, Y., Clow, F., Fung, J. J., Fraser, J. D., & Lin, F. (2016). Therapeutic potential of staphylococcal superantigen-like protein 7 for acute complement activation-mediated diseases. Paper presented at XXVI International Complement Workshop, Kanazawa, Japan. 4 September - 8 September 2016. Immunobiology: SI: XXVI ICW Kanazawa 2016. (pp. 1). 10.1016/j.imbio.2016.06.055


Contact details

Alternative contact

Salome Schlebusch
Executive Assistant to the Dean
DDI: +64 (0) 9 923 6740

Primary office location

M&HS BUILDING 505 - Bldg 505
Level 1, Room 101A
New Zealand

Web links